Media LibraryContact Us
Products Corporate Tissue Services
Search
LifeCell's Technology
Research & Development
Investor Relations
Stock Quote
Stock Chart
SEC Filings
Historical Price Lookup
Senior Management Team
Governance
Press Releases
Career Opportunities
Regulatory Licensing Documentation
Quality Policy

Investor Relations

Our Mission
To be a leader in the emerging field of regenerative medicine by delivering significant clinical benefit to our customers through innovative, biologically-based products for the repair and replacement of human tissue.

Read More
Latest Webcasts
Latest Press Releases
04/24/08
LifeCell Reports First Quarter 2008 Financial Results. Product Revenues Up 27%

04/07/08
KCI to Acquire LifeCell for $1.7 Billion in Cash Creating a Global Medical Technology Leader

View All Press Releases
Company Profile
LifeCell develops and markets tissue repair products for use in reconstructive, reconstructive, urogynecologic and orthopedic surgical procedures. LifeCell's current marketed products include: AlloDerm®, for plastic reconstructive, general surgical, burn and periodontal procedures; Cymetra®, a particulate form of AlloDerm suitable for injection; Repliform®, for urogynecologic surgical procedures; GraftJacket®, for orthopedic surgical procedures; and AlloCraft™DBM, for bone grafting procedures.


Stock Quote
(LIFC : NASDAQ)
4:00 PM EST, 05/13/08
Last: 50.92
Change: 0.110  0.22%
Latest SEC Filings
Form SC TO-T/A (05/13/08)
Form SC 14D9/A (05/12/08)
Form SC 14D9/A (05/09/08)
Form 4 (05/07/08)
Form 4 (05/07/08)
2006 Annual Report
2006 Form 10-K
Download PDF
Email Alerts
Sign Up For Email Alerts
Investor Presentation
Download